LDS/Medical Tests/Vitamin B12 Binding Capacity

Vitamin B12 Binding Capacity

Vitamin B12 is transported throughout the body via proteins called transcobalamins. These vitamin transport proteins are found in the blood, saliva, tissues, tears and milk. The major transport protein for B12 is Transcobalamin I (TCI, also known as haptocorrin and R-factor or R-protein). This protein transports about 80-90% of vitamin B12 and is responsible for transporting B12 to the liver and the enterohepatic circulation.  Haptocorrin releases B12 to Intrinsic Factor under the influence of pancreatic protease.  The major function of TCI seems to be to bind to vitamin B12 in the oral cavity during eating and then protect it as it passes through the acidic environment of the stomach, since B12 is sensitive to acid and degraded by it.  

The B12-transcobalamione complex is known as holohaptocorrin and the B12-transcobalamine II complex is known as holotranscobalamine (Holo-TC).  Transcobalamin II (TCII) binds a smaller amount of vitamins (10-25%) in plasma, but is responsible for most of the unsaturated B12 binding capacity (UBBC). TCI and TCII can be indicative of certain disease states. TCII bound vitamin B12 is decreased in untreated vitamin B12 deficiency. UBBC will continue to rise as the vitamin B12 deficiency progresses. TCI is shown to be increased in myeloproliferative disorders, polycythemia vera, myelofibrosis, chronic myelogenous leukemia, hepatoma, and metastatic cancer. TCII is increased in myeloproliferative disorders, liver disease, inflammatory disorders, and Gaucher disease. UBBC can also be increased in pregnancy and with the use of contraceptive hormones. TCII can be decreased in some shortly after birth presenting with vomiting, weakness, pancytopenia, and megaloblastic anemia, but is very rare. TCI deficiency shows no signs of vitamin B12 deficiency and is very rare. The B12 binding capacity test is required to diagnose TCI and TCII deficiencies.

  • Diagnosis of myloproliferative disorders such as polycythemia vera, myelofibrosis, chronic myelogenous leukemia
  • Monitor polycythemia vera disease activity
  • As an aid in diagnosis of megaloblastic anemia or Transcobalamin deficiency in infants

Increased in:

  • Myeloproliferative disorders
  • Lymphoproliferative disorders
  • Polycythemia vera
  • Myelofibrosis
  • Chronic myelogenous leukemia
  • Hepatoma
  • Metastatic cancer
  • Autoimmune diseases

Decreased in:

  • Megaloblastic anemia of infants
  • Transcobalamin deficiency, congenital or functional

800-2600 pg/mL
 

 

 

Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA), High-Performance Liquid Chromatography Mass spectrometry (HPLC/MS).

Serum (SST). 

Stability

  • Ambient: unacceptable 
  • Refrigerated: unacceptable 
  • Frozen: 30 days

Specimen should be protect from light and shipped frozen.

Vitamin B12, Folate, Methylmalonic acid (MMA) serum or urine, CBC with differential, Helicobacter pylori, Homocysteine, Erythropoietin, Iron, Iron saturation, hemochromatosis.
1-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Br Med J (Clin Res Ed). 1982 September 25; 285(6345): 840-842. [PMID: 6288165]
  • Lab Invest. 1988 Mar;58(3):332-7. [PMID: 3347009]
  • Blood. 1975 Feb;45(2):287-93. [PMID: 1054610]
  • David S. Jacobs. Laboratory Test Handbook. Hudson, OH, Lexi-Comp Inc (1996); Page 1316.